Calcitriol

Specifications

32222-06-3CAS Number

250-963-8EC Number

trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diolIUPAC Name

C27H44O3Chemical Formula

416.6 g/molMolecular Weight

calcitriol; Rocaltrol; 32222-06-3; Calcijex; Topitriol; 1alpha,25-Dihydroxyvitamin D3; Soltriol; Silkis; 1alpha,25-Dihydroxycholecalciferol; Dihydroxyvitamin D3; Vectical; 1,25-DHCC; Calcitriolum; 1,25-DIHYDROXYCHOLECALCIFEROL; 1alpha,25(OH)2D3; Ro 21-5535; 1-alpha,25-Dihydroxyvitamin D3; 1,25-Dihydroxycholecaliferol; Decostriol; 1a,25-Dihydroxycholecalciferol; Ro-21-5535; (1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol; FXC9231JVH; DN 101; Ro 215535; Ro-215535; 1,25-(OH)2D3; DTXSID5022722; CHEBI:17823; 1-alpha-25-dihydroxyvitamin D3; U 49562; 1,25 Dihydroxycholecalciferol; (1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol; (5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol; (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-; (1S,3R,5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol; (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol; 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL; 1 alpha, 25-dihydroxy-20-epi-Vitamin D3; DTXCID002722; calcitriolo; DTXSID80873390; Calcitrol; Calcitriol Nefro; 1 alpha,25-Dihydroxyvitamin D3; (1R,3S,5Z)-5-((2E)-2-((1R,3aS,7aR)-1-((2R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene)ethylidene)-4-methylidenecyclohexane-1,3-diol; (1R,3S,5Z)-5-(2-((1R,3aS,4E,7aR)-1-((2R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-octahydro-1H-inden-4-ylidene)ethylidene)-4-methylidenecyclohexane-1,3-diol; 1,25(OH)2-20epi-D3; 5-(2-(1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE)-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL; KyraMed, Calcitriol; 1,25-dihydroxy-20-epi-Vitamin D3; Dihydroxyvitamin D 3; MC-1288; dihydroxycholecalciferol; Calcitriol 0.25 mcg; RefChem:56860; 1,25 Dihydroxyvitamin D3; Calcitriol Capsules 0.5 mcg; D3, 1,25-Dihydroxyvitamin; Calcitriol Capsules 0.25 mcg; 1 alpha,25 Dihydroxyvitamin D3; A11CC04; D05AX03; DTXCID30820910; D3, 1 alpha,25-Dihydroxyvitamin; 1 alpha,25-Dihydroxycholecalciferol; 1,25 dihydroxy 20 epi Vitamin D3; D3, 1,25-dihydroxy-20-epi-Vitamin; MC 1288; 1,25(OH)2-D3; 1, 25-(OH)2D3; 250-963-8; 1,25-Dihydroxyvitamin D; 1a,25-Dihydroxyvitamin D3; DN-101; MFCD00867079; CHEMBL846; 1,25-dihydroxy vitamin D3; Toptriol; (5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol; Calcitriol Impurities A; (1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol; 1alpha,25-Dihydroxyvitamin D; (1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol; (5Z,7E)-(1S,3R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol; Calcitriolum [INN-Latin]; 1000873-74-4; SMR000466393; CCRIS 5522; dihydroxy-vitamin D3; HSDB 3482; (1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol; EINECS 250-963-8; 25-dihydroxycholecalciferol; UNII-FXC9231JVH; Asentar; Panbonis; 1,25-(OH)2-D3; 1.alpha.,25-dihydroxycholecalciferol; Calcitriol CRS; Calcitriol; (5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta.,5Z,7E)-; 1alpha 25-dihydroxycholecalciferol; Rocaltrol (TN); Calcitriol (1,25-Dihydroxyvitamin D3); NCGC00161327-04; (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol; (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol; 73837-24-8; Calcitriol [USAN:USP:INN:BAN:JAN]; Calcitriol (Standard); Cholecalciferol, 1-alpha,25-dihydroxy-; 1db1; starbld0021993; CALCITRIOL [MI]; CALCITRIOL [INN]; CALCITRIOL [JAN]; Spectrum5_002061; CALCITRIOL [HSDB]; CALCITRIOL [USAN]; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol; CALCITRIOL [VANDF]; Epitope ID:547904; CALCITRIOL [MART.]; SCHEMBL3245; CALCITRIOL [USP-RS]; CALCITRIOL [WHO-DD]; 1alpha,25(OH)2-D3; BSPBio_001287; Calcitriol (JAN/USP/INN); MLS000759536; MLS001424122; BML2-E03; GTPL2779; orb1300876; orb3140997; CALCITRIOL [ORANGE BOOK]; BCBcMAP01_000160; CHEBI:93988; CALCITRIOL [EP MONOGRAPH]; CALCITRIOL [USP MONOGRAPH]; HMS1361A09; HMS1791A09; HMS1989A09; HMS2051F06; HMS2089N03; HMS2232D18; HMS3402A09; EX-A4435; 1,25 DIHYDROXY VITAMIN D3; 1a,25-(OH)2D3; BDBM50200182; EBC-27024; HY-10002R; LMST03020258; MSK1514-100Y; NSC749776; 1-alpha,-1,25-Dihydroxyvitamin D3; AKOS015961898; AC-1859; CCG-101001; CD-2027; CS-0388; DB00136; FC09794; NC00251; NSC-749776; 1,25(OH2)D3; IDI1_033757; 1,25(OH)2D3 & CD4; 1,25-Dihydroxy Vitamin D3; Calcitriol; Calcitrol 100 microg/mL in Acetonitrile; NCGC00161327-01; NCGC00161327-07; 1.alpha.,25-Dihydroxyvitamin D(sub 3); 66772-14-3; CPD000466393; HY-10002; C3078; NS00004734; T6316; 1alpha,25-dihydroxycholecalciferol; calcitriol; Vitamin D3-1alpha,25-dihydroxy (Calcitriol); 1,25D3; C01673; D00129; AB00639957-06; AB00639957_07; 1,25-DIHYDROXYCHOLECALCIFEROL, (1ALPHA)-; 1alpha,25-Dihydroxyvitamin D3, >=99% (HPLC); EN300-22411582; Q139195; SR-01000759361; SR-01000946978; 1alpha,25-Dihydroxyvitamin D3, >=97.0% (HPLC); SR-01000759361-4; SR-01000946978-1; 1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3; BRD-K27316855-001-06-7; BRD-K27316855-001-13-3; BRD-K27316855-001-15-8; BRD-K27316855-001-19-0; (3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol; Calcitriol, European Pharmacopoeia (EP) Reference Standard; 1alpha,25-Dihydroxy vitamin D3 Solution in Ethanol, 100ug/mL; (5Z,10-secocholesta-5,7,10(19)-triene-1.alpha.,3.beta.,25-triol; (1S,3R,5Z,7E,14beta,17alpha)-9,10-secocholesta-5,7,10-triene-1,3,25-triol; 1alpha,25-dihydroxyvitamin D3 / 1alpha,25-dihydroxycholecalciferol / calcitriol; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)-; 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4; (1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol; 1,3-Cyclohexanediol, 4-methylene-5-[2-[(1R,3aS,7aR)-octahydro-1-[(1R)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3S)-; Rocaltrol; (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol; trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diolSynonyms